Analyst Price Targets — KRMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 6, 2026 1:25 pm | Chase Knickerbocker | Craig-Hallum | $6.00 | $3.60 | TheFly | Koru Medical price target lowered to $6 from $7 at Craig-Hallum |
| January 13, 2026 2:09 pm | — | Craig-Hallum | $7.00 | $5.75 | TheFly | Koru Medical price target raised to $7 from $6.25 at Craig-Hallum |
| December 22, 2025 1:43 pm | — | Lake Street | $8.00 | $6.03 | TheFly | Koru Medical price target raised to $8 from $6 at Lake Street |
| December 17, 2025 12:26 pm | — | Canaccord Genuity | $6.00 | $5.77 | TheFly | Koru Medical price target raised to $6 from $5 at Canaccord |
| November 14, 2024 12:19 pm | Matthew O\'Brien | Piper Sandler | $3.50 | $3.10 | StreetInsider | Koru Medical Systems Inc. (KRMD) PT Raised to $3.50 at Piper Sandler |
| July 2, 2024 10:05 am | Kyle Rose | Canaccord Genuity | $3.00 | $2.25 | StreetInsider | Canaccord Genuity Bullish on Koru Medical Systems Inc. (KRMD) |
| January 6, 2023 6:56 am | — | Piper Sandler | $4.50 | $3.70 | Benzinga | Piper Sandler Maintains Overweight on KORU Medical Systems, Raises Price Target to $4.5 |
| May 5, 2022 4:43 am | Jason Bednar | Piper Sandler | $3.00 | $2.80 | TheFly | Koru Medical investment spend to remain elevated, says Piper Sandler |
Latest News for KRMD
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
KORU Medical Systems NASDAQ: KRMD reported second-quarter revenue of $12 million, up 18% from a year earlier, as domestic patient starts, market-share gains and international demand supported growth. The company also said it achieved positive net income for the first time since 2019 and raised its full-year gross-margin outlook, while narrowing revenue guidance because certain international prefilled-syringe market…
KORU Medical Systems, Inc. (KRMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to break-even earnings per share a year ago.
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year…
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026. KORU…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for KRMD.
U.S. House Trading
No House trades found for KRMD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.